Photodynamic Therapy in the Treatment of Choroidal Neovascularization Complicating Central Serous Chorioretinopathy

Journal of the Chinese Medical Association

Volumn 72, Issue 9, 2009, Pages 501-505

  Yang, Chang Sue ^a,b   Chen, Kuan Chieh ^a   Lee, Shui Mei ^a,b   Lee, Fenq Lih ^a,b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

central serous chorioretinopathy; choroidal neovascularization; photodynamic therapy; verteporfin

Indexed keywords

FLUORESCENT DYE; VERTEPORFIN;

ADULT; ARTICLE; CASE REPORT; CENTRAL SCOTOMA; CENTRAL SEROUS RETINOPATHY; FLUORESCENCE ANGIOGRAPHY; HUMAN; INDOCYANINE GREEN ANGIOGRAPHY; MALE; METAMORPHOSIS; PHOTODYNAMIC THERAPY; PIGMENT EPITHELIUM; RECURRENT DISEASE; RETINA EXUDATE; RETINA MACULA HEMORRHAGE; SUBRETINAL NEOVASCULARIZATION; TREATMENT RESPONSE; VISUAL ACUITY; VISUAL IMPAIRMENT;

ADULT; CENTRAL SEROUS CHORIORETINOPATHY; CHOROIDAL NEOVASCULARIZATION; HUMANS; MALE; PHOTOCHEMOTHERAPY; PORPHYRINS;

EID: 70449368396     PISSN: 17264901     EISSN: 17287731     Source Type: Journal    
DOI: 10.1016/S1726-4901(09)70417-4     Document Type: Article

References (14)

1. Loo R.H., Scott I.U., Flynn Jr. H.W., Gass J.D., Murray T.G., Lewis M.L., Rosenfeld P.J., et al. Factors associated with reduced visual acuity during long-term follow-up of patients with idiopathic central serous chorioretinopathy. Retina 22 (2002) 19-24
2. Cooper B.A., and Thomas M.A. Submacular surgery to remove choroidal neovascularization associated with central serous chorioretinopathy. Am J Ophthalmol 130 (2000) 187-191
3. Chan W.M., Lam D.S., Lai T.Y., Tam B.S., Liu D.T., and Chan C.K. Choroidal vascular remodeling in central serous chorioretinopathy after indocyanine green guided photodynamic therapy with verteporfin: a novel treatment at the primary disease level. Br J Ophthalmol 87 (2003) 1453-1458
4. Taban M., Boyer D.S., Thomas E.L., and Taban M. Chronic central serous chorioretinopathy: photodynamic therapy. Am J Ophthalmol 137 (2004) 1073-1080
5. Chan W.M., Lam D.S., Lai T.Y., Yuen K.S., Liu D.T., Chan C.K., and Chen W.Q. Treatment of choroidal neovascularization in central serous chorioretinopathy by photodynamic therapy with verteporfin. Am J Ophthalmol 136 (2003) 836-845
6. Ergun E., Tittl M., and Stur M. Photodynamic therapy with verteporfin in subfoveal choroidal neovascularization secondary to central serous chorioretinopathy. Arch Ophthalmol 122 (2004) 37-41
7. Cardillo Piccolino F., Eandi C.M., Ventre L., Rigault de la Longrais R.C., and Grignolo F.M. Photodynamic therapy for chronic central serous chorioretinopathy. Retina 23 (2003) 752-763
8. Guyer D.R., Yannuzzi L.A., Slakter J.S., Sorenson J.A., Ho A., and Orlock D. Digital indocyanine green videoangiography of central serous chorioretinopathy. Arch Ophthalmol 112 (1994) 1057-1062
9. Yannuzzi L.A., Slakter J.S., Gross N.E., Spaide R.F., Costa D.L., Huang S.J., Klancnik Jr. J.M., et al. Indocyanine green angiography-guided photodynamic therapy for treatment of chronic central serous chorioretinopathy: a pilot study. Retina 23 (2003) 288-298
10. Sasahara M., Tsujikawa A., Musashi K., Gotoh N., Otani A., Mandai M., and Yoshimura N. Polypoidal choroidal vasculopathy with choroidal vascular hyperpermeability. Am J Ophthalmol 142 (2006) 601-607
11. Yannuzzi L.A., Freund K.B., Goldbaum M., Scassellati-Sforzolini B., Guyer D.R., Spaide R.F., Maberley D., et al. Polypoidal choroidal vasculopathy masquerading as central serous chorioretinopathy. Ophthalmology 107 (2000) 767-777
12. Cervera E., Montero J., Torralba C., Palomares P., and Hernández M. Low dose photodynamic therapy for chronic central serous chorioretinopathy. Arch Soc Esp Oftalmol 83 (2008) 525-526
13. Chan W.M., Lai T., Lai R., Liu D.T.L., and Lam D.S.C. Half-dose verteporfin photodynamic therapy for acute central serous chorioretinopathy. Ophthalmology 115 (2008) 1756-1765
14. Goldstein M., Heilweil G., Barak A., and Loewenstein A. Retinal pigment epithelial tear following photodynamic therapy for choroidal neovascularization secondary to AMD. Eye 19 (2005) 1315-1324